Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
ARCK was delisted on the 12th of January, 2023.
2 hedge funds and large institutions have $18.7K invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 61 closing their positions.
97% less funds holding
Funds holding: 62 → 2 (-60)
98% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 61
100% less capital invested
Capital invested by funds: $152M → $18.7K (-$152M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$16.5M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$8.91M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$7.35M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$6.77M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.1M |
ARCK Hedge Fund Activity: Q4 2022 in Review
2 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q4 2022, worth a combined $18.7K — down 100% from $152M a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of ARCK and 1 opened new positions — a net loss of 60 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $4K. The largest seller was Saba Capital Management, exiting entirely with an estimated $16.5M sold.
- 2 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q4 2022, down from 62 in Q3 2022.
- Funds reported $18.7K of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
- 1 fund opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q4 2022 and 61 closed out, a net change of -60 holders.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q4 2022 was UBS Group, an estimated $4K added.
- The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q4 2022 was Saba Capital Management, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2022.